Therapeutic Solutions International Stock Forecast, Price & News

Therapeutic Solutions International (OTCMKTS:TSOI) Frequently Asked Questions

How has Therapeutic Solutions International's stock been impacted by Coronavirus (COVID-19)?

Therapeutic Solutions International's stock was trading at $0.0016 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TSOI stock has increased by 1,443.8% and is now trading at $0.0247.
View which stocks have been most impacted by COVID-19.

Are investors shorting Therapeutic Solutions International?

Therapeutic Solutions International saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 135,300 shares, an increase of 366.6% from the December 15th total of 29,000 shares. Based on an average daily trading volume, of 37,451,200 shares, the days-to-cover ratio is presently 0.0 days.
View Therapeutic Solutions International's Short Interest.

Who are Therapeutic Solutions International's key executives?

Therapeutic Solutions International's management team includes the following people:

• Timothy G. Dixon, Chairman, President & Chief Executive Officer
• James Veltmeyer, Chief Medical Officer
• Feng Lin, Chief Scientific Officer
• Famela Ramos, Vice President-Business Development
• Serena Robella, Sales Director

Who are some of Therapeutic Solutions International's key competitors?

Some companies that are related to Therapeutic Solutions International include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), ALK-Abello A/S (AKBLF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX) and Anatara Lifesciences (ANR).
View all of TSOI's competitors.

What other stocks do shareholders of Therapeutic Solutions International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD).

What is Therapeutic Solutions International's stock symbol?

Therapeutic Solutions International trades on the OTCMKTS under the ticker symbol "TSOI."

How do I buy shares of Therapeutic Solutions International?

Shares of TSOI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Therapeutic Solutions International's stock price today?

One share of TSOI stock can currently be purchased for approximately $0.02.

How many employees does Therapeutic Solutions International have?

Therapeutic Solutions International employs 4 workers across the globe.

What is Therapeutic Solutions International's official website?

The official website for Therapeutic Solutions International is therapeuticsolutionsint.com.

Where are Therapeutic Solutions International's headquarters?

Therapeutic Solutions International is headquartered at 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States.

How can I contact Therapeutic Solutions International?

Therapeutic Solutions International's mailing address is 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States. The company can be reached via phone at (760) 295-7208.